Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;48(5):1110-1115.
doi: 10.1111/jog.15201. Epub 2022 Feb 25.

Intravaginal misoprostol versus uterine curettage for missed abortion: A cost-effectiveness analysis

María Dolores Torres-Miranda  1 , Jorge Duro Gómez  1 , Sonja Peña Lobo-Gonçalves  1 , Antonio Jesús De la Torre González  1 , Camil Castelo-Branco  2
Affiliations

Intravaginal misoprostol versus uterine curettage for missed abortion: A cost-effectiveness analysis

María Dolores Torres-Miranda et al. J Obstet Gynaecol Res. 2022 May.

Abstract

Purpose: To evaluate the cost-effectiveness of a strategy based on direct-acting uterine curettage (UC) versus a pre-direct-acting misoprostol (1600 mg) in patients with missed abortion (MA), from the perspective of a National Health System.

Methods: An open prospective cohort study was carried out at Reina Sofía University Hospital (Córdoba, Spain) from January 1, 2019 to December 31, 2019 in 180 patients diagnosed with MA. The patients chose medical treatment with intravaginal misoprostol (800 μg/4 h) or UC after receiving complete and detailed information. The effectiveness, clinical characteristics of the patients, costs of treating and managing the disease, and satisfaction with the procedures were recorded.

Results: One hundred and forty-five patients (80.6%) chose misoprostol versus 35 patients (19.4%) who chose UC. The effectiveness of misoprostol has been 42% evaluated at 48 h; UC success rate has been 100%. The incidence of side effects is significantly higher in patients treated with misoprostol (p < 0.05); as well as the number of care received by the patient (p < 0.05). Satisfaction is higher in patients treated with UC (p < 0.05). However, the cost is almost 5-folds higher in patients treated with UC (p < 0.05).

Conclusion: UC has a higher success rate, greater satisfaction, and a lower incidence of side effects, although significantly increases the cost compared to misoprostol in MA.

Keywords: curettage; effectiveness; misoprostol; missed abortion; satisfaction.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. OMS/VVHO. International recommendations on definitions of live birth and fetal death. Geneve CH: Federal Security Agency. Public Health Service, National Office of Vital Statistics; 1950.
    1. Aborto espontáneo. Protocolo asistencial en obstetricia de la SEGO. Actualizado en julio de 2010. Disponible en: http://www.prosego.com.
    1. Ruipérez Pacheco E, De la Puente YM, Izquierdo Méndez N, Asenjo de la Fuente E, Herráiz Martínez MÁ, Vidart Aragón JA. Medical treatment of spontaneous abortion in the first trimester. Cli Invest Gin Obst. 2015;42(3):112-7.
    1. Harris LH, Dalton VK, Johnson TRB. Surgical management of early pregnancy failure: history, politics, and safe, cost-effective care. Am J Obstet Gynecol. 2007;196(445):e1-445.e5.
    1. Joaquín EV, Milena SB, Felipe RZ, Francisco SU, Carlos RF-D, Fernando TR. Efectividad del tratamiento médico con misoprostol según dosis administrada en aborto retenido menor de 12 semanas. Rev Chil Obstet Ginecol. 2014;79(2):76-80.

Substances

LinkOut - more resources